Fin Trust Capital Advisors, LLC Cara Therapeutics, Inc. Transaction History
Fin Trust Capital Advisors, LLC
- $510 Million
- Q1 2024
A detailed history of Fin Trust Capital Advisors, LLC transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 260 shares of CARA stock, worth $67. This represents 0.0% of its overall portfolio holdings.
Number of Shares
260
Previous 260
-0.0%
Holding current value
$67
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CARA
# of Institutions
102Shares Held
21.5MCall Options Held
50KPut Options Held
0-
Black Rock Inc. New York, NY3.42MShares$889,5540.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.48MShares$645,1270.0% of portfolio
-
Disciplined Growth Investors Inc Minneapolis, MN1.82MShares$471,9150.03% of portfolio
-
Chescapmanager LLC Baltimore, MD1.7MShares$442,5480.15% of portfolio
-
Farallon Capital Management LLC San Francisco, CA1.56MShares$404,6250.01% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $14M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...